Cresset Asset Management »

Gain Therapeutics shares owned by Cresset Asset Management

Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by Cresset Asset Management from 13F filings

Historical chart of Cresset Asset Management investment in Gain Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Gain Therapeutics held by Cresset Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gain Therapeutics by Cresset Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $515k 160k 3.22

More positions owned by Cresset Asset Management

Arista Networks Com Shs (ANET)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Apple (AAPL)
Erie Indty Cl A (ERIE)
Ishares Tr Core Msci Eafe (IEFA)
Meta Platforms Cl A Call Option (META)
Reddit Cl A (RDDT)
Ishares Tr Core S&p Scp Etf (IJR)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Palantir Technologies Cl A (PLTR)
Ishares Tr S&p 100 Etf (OEF)

View all positions for Cresset Asset Management

Top funds holding Gain Therapeutics

Marshall Wace
Potomac Capital Management
Susquehanna International
Jones Financial Companies, L.L
Vanguard Group
Cambridge Investment Research Advisors
DME Capital Management
Geode Capital Management
Citadel Advisors
Jane Street
BlackRock
Cresset Asset Management
State Street Corporation
LPL Financial
Northern Trust

View all funds holding Gain Therapeutics